Alps Advisors Inc Esperion Therapeutics, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$4.81 - $11.92 $166,680 - $413,063	-34,653 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $28,123 - $52,997	-2,480 Reduced 6.68%	34,653 $418,000
Q2 2021 Aug 11, 2021	SELL	$19.4 - $28.71 $257,942 - $381,728	-13,296 Reduced 26.37%	37,133 $785,000
Q1 2021 May 07, 2021	BUY	$25.12 - $36.89 $3,391 - $4,980	135 Added 0.27%	50,429 $1.42 Million
Q4 2020 Feb 03, 2021	BUY	$24.2 - $35.76 $1.22 Million - $1.8 Million	50,294 New	50,294 $1.31 Million

211

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.